Different Metabolic Responses in α-, β-, and δ-Cells of the Islet of Langerhans Monitored by Redox Confocal Microscopy  by Quesada, Ivan et al.
Different Metabolic Responses in a-, b-, and d-Cells of the Islet of
Langerhans Monitored by Redox Confocal Microscopy
Ivan Quesada, Mariana G. Todorova, and Bernat Soria
Institute of Bioengineering, Miguel Hernandez University, Sant Joan d’ Alacant, Spain
ABSTRACT Blood glucose homeostasis is mainly achieved by the coordinated function of pancreatic a-, b-, and d-cells, which
secrete glucagon, insulin, and somatostatin, respectively. Each cell type responds to glucose changes with different secretion
patterns. Currently, considerable information can be found about the signal transduction mechanisms that lead to glucose-
mediated insulin release in the pancreatic b-cell, mitochondrial activation being an essential step. Increases in glucose
stimulate the mitochondrial metabolism, activating the tricarboxylic acid cycle and raising the source of redox electron carrier
molecules needed for respiratory ATP synthesis. However, little is known about the glucose-induced mitochondrial response of
non-b-cells and its role in the stimulus-secretion coupling process. This limited information is probably a result of the scarcity of
these cells in the islet, the lack of identiﬁcation patterns, and the technical limitations of conventional methods. In this study, we
used ﬂavin adenine dinucleotide redox confocal microscopy as a noninvasive technique to speciﬁcally monitor mitochondrial
redox responses in immunoidentiﬁed a-, b-, and d-cells in freshly isolated intact islets and in dispersed cultured cells. We have
shown that glucose provokes metabolic changes in b- and d-cell populations in a dose-dependent manner. Conversely, no
signiﬁcant responses were observed in a-cells, despite the sensitivity of their metabolism to drugs acting on the mitochondrial
function, and their intact ability to develop Ca21 signals. Identical results were obtained in islets and in cultures of dispersed
cells. Our ﬁndings indicate metabolic differences in glucose utilization among the a-, b-, and d-cell populations, which might be
important in the signal transduction events that lead to hormone release.
INTRODUCTION
The islet of Langerhans is the main endocrine unit control-
ling glucose homeostasis (1,2). Its function is the result of the
interaction and secretion of many glucose-sensitive cell
types, including b (60–80% of islet cells), a (10–15%), and
d-cells (5–10%), among others (1,3,4). Whereas a-cells
release the hyperglycemic hormone glucagon when extra-
cellular glucose concentrations become low, pancreatic
b-cells secrete insulin in response to high concentrations of
sugar to restore normal levels (1,3–5). Thus, the antagonist
action of both hormones ensures glycemia within a physio-
logical range. Additionally, somatostatin-containing d-cells
affect glucose homeostasis through the paracrine modulation
of the neighboring a- and b-cells (6–8). Failures in this
system may lead to the widespread disease diabetes mellitus
(2). Despite the importance of non-b-cells for the whole islet
function, the vast majority of studies have been focused on
the b-cell physiology.
This insufﬁcient knowledge about non-b-cells is partly
due to both the scarcity of these cell types in the islet, and the
lack of identiﬁcation patterns. Additionally, it has been
proved that the use of conventional techniques to monitor
physiological parameters of non-b-cells in the intact islet is
difﬁcult and, to some extent, unsuccessful. Recently, some
groups, as well as ours, have characterized the individual
electrophysiological properties and Ca21 signals in re-
sponse to glucose of the main cell types in the intact islet of
Langerhans (4,9–11). These studies have also demonstrated
the existence of differences in the physiological behavior when
data from dispersed cultured islet cells and fresh intact islets
are compared. Undoubtedly, the latter is the model whose
behavior is closer to the physiological scenario (12,13).
Although these studies have contributed important physio-
logical information, the data about the signal transduction
pathway that leads to secretion in non-b-cells is still scarce,
especially concerning events involved in cell metabolism.
In the case of the pancreatic b-cell, extracellular glucose is
carried through membrane transporters into the cytosol,
where it is then metabolized into pyruvate by glycolysis (14).
Pyruvate enters the mitochondria and is further metabolized
via the tricarboxylic acid (TCA) cycle, producing CO2
and the nucleotide carriers of reducing power, NADH and
FADH2 (14–18). These molecules serve as a source of elec-
tron transfer in the chain of oxidative phosphorylation
reactions that mediate ATP production. The increase in the
ATP/ADP ratio is the main cause for the closure of ATP-
dependent K1 (KATP) channels, which leads to membrane
depolarization and the increase in cytosolic [Ca21] through
the activation of voltage-dependent Ca21 channels (2,19–21).
This Ca21 signal triggers insulin secretion. Although cytosolic
glycolysis is coupled to a limited production of ATP and
NADH, the major source of ATP and redox molecules
comes from the oxidative mitochondrial metabolism (14,17).
Thus, mitochondrial activation is a crucial step in the
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signal-transduction events that lead to ATP-dependent insulin
release in the pancreatic b-cell (14,17).
Most of the information about islet metabolism comes
from biochemical studies. Notwithstanding the importance
of this classical methodology, optical techniques combined
with imaging have unique advantages to study the temporal
and spatial pattern of different physiological parameters.
Particularly, redox microﬂuorometry has been used as a non-
invasive tool to monitor islet metabolism. The basis of this
technique counts on the ﬂuorescence properties of both
NAD1- and NADP1 (NAD(P)1)- and ﬂavin adenine dinu-
cleotide (FAD)-linked proteins (ﬂavoproteins) and their asso-
ciated intensity changes, depending on the cellular metabolic
redox state (22). Whereas ﬂuorescence is increased with the
reduction of NAD(P)1 into NAD(P)H, in the case of ﬂavo-
proteins, the ﬂuorescence intensity is higher for the oxidized
form (FAD), and lower for the reduced molecule (FADH2).
Thus, these two molecules produce opposite ﬂuorescence
proﬁles when a change in the metabolic status takes place.
Since NAD(P)H is produced by glycolysis and the TCA
cycle, the ﬂuorescence signal comes from both compart-
ments, the cytosol and the mitochondria (22). Conversely,
the changes in ﬂavoprotein ﬂuorescence provide a better
approach to monitor mitochondrial activation, since the
reduction of these molecules occurs at the level of this
intracellular organelle. However, although this methodology
has been successful to investigate b-cell metabolism (16),
redox ﬂuorometry combined with conventional microscopy
is not useful to spatially and temporally resolve the metab-
olic signal from non-b-cells in the intact islet. Indeed, this
technique essentially detects the average signal, which is
dominated by the most abundant population, the b-cell (4).
This limitation can be mostly overcome using optical sec-
tioning techniques. In this study, we have monitored FAD
ﬂuorescence signals using confocal microscopy to study the
mitochondrial responses from individual a-, b-, and d-cells
in the intact islet of Langerhans and in dispersed cells in
culture. Important metabolic differences in response to
glucose are shown among the main islet cell types. These
observations suggest important discrepancies about the
stimulus-secretion coupling scheme of islet cells, especially
when metabolic events are considered.
MATERIALS AND METHODS
Islet and cell isolation
All experiments were conducted according to regulations approved by our
institution. Swiss albino OF1 mice (8–10 weeks old) were sacriﬁced by
cervical dislocation, and pancreatic islets were then isolated by collagenase
digestion as previously described (11,23). Intact islets were placed in a cell-
culture chamber at 37C for 30 min before the experiments. Some islets were
dispersed into single cells and clusters by enzymatic digestion in the
presence of 0.05% trypsin and 0.02% EDTA for 2 min. Cells and clusters
were plated onto poly-L-lysine-treated coverslips and cultured overnight in
RPMI 1640 (Invitrogen, Barcelona, Spain) supplemented with 10% fetal calf
serum, 100 IU/ml penicillin, 0.1 mg/ml streptomycin, and 5.6 mmol/L
glucose (11,23). All experiments were carried out at 37C.
Redox confocal microscopy
Intact islets were allowed to become attached onto poly-L-lysine-treated
coverslips for 10 min before experiments. Islets or dispersed cells were then
placed on a perfusion chamber mounted on the stage of a Zeiss LSM 510
laser confocal microscope system, and perfused at a rate of 1 ml/min in a
Krebs-Ringer buffer (in mmol/L): 115 NaCl, 5 KCl, 10 NaHCO3, 1.2
KH2PO4, 1.1 MgCl2, 2.5 CaCl2, 25 HEPES, and different concentrations of
glucose (pH 7.4). Fluorescence was monitored using a 403 oil immersion
objective (numerical aperture 1.3). Confocal conﬁguration was set to obtain
optical sections of 6–8 mm and to optimize the capture of ﬂuorescence
changes from the FAD-linked proteins of our samples. Flavoprotein
autoﬂuorescence was excited at 488 nm with an argon laser, and the
emission was collected with a bandpass at 505–550 nm. Two or four images
were averaged for each acquisition point (1 point/2 s or 1 point/4 s).
Temporal series were ﬁltered with a spatial low-pass ﬁlter and processed
using the digital image software of the Zeiss LSM 510 confocal microscope.
The output of the 15-mW laser was adjusted around the minimum intensity
(3%). The majority of experiments lasted .50 min. For these experiments,
the interval time between each acquisition was set to 30–60 s. This sampling
rate and laser intensity provided enough spatial resolution with a negligible
photobleaching. For some shorter experiments the interval time was 5 s.
Higher laser intensities improved the quality of the autoﬂuorescence images
but increased photobleaching (Fig. 1). Background was calculated by mea-
suring ﬂuorescence in a cell-free area of interest, and it was then subtracted
from the records.
Immunocytochemistry
Once ﬂavoprotein ﬂuorescence changes had been recorded, intact islets
or dispersed cells were washed for 10 min with phosphate-buffered saline,
ﬁxed using 1% (w/v) paraformaldehyde for 10 min, and permeabilized with
0.5% Triton X-100 for 10 min, as previously described (4,11) . To reduce
nonspeciﬁc antibody binding, cells were ﬁrst preincubated with a blocking
buffer (2% goat serum in phosphate-buffered saline) for 15 min at room
temperature before primary antibodies were applied in the same buffer. An
antiinsulin monoclonal antibody (1:1000 dilution; Sigma, Barcelona, Spain),
an antiglucagon monoclonal antibody (1:1000 dilution; Sigma), or an anti-
somatostatin rabbit polyclonal antibody (1:300 dilution, Dakocytomation,
FIGURE 1 Autoﬂuorescence in intact islets. Images of the ﬂuorescence
emission of two islets excited with a 15-mW argon laser at 488 nm. Emission
was collected with a bandpass ﬁlter at 505–550 nm. The laser intensity was
adjusted to 3% in the case of the islet shown in A, and at 10% in B. A laser
intensity of 3% allowed temporal series of well-contrasted images without
detectable photobleaching (please see Materials and Methods). Optical
section, 6 mm; scale bar, 100 mm.
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Barcelona, Spain) was applied for 3 h. After washing, ﬂuorescein-
isothiocyanate- or tetramethyl-rhodamine-isothiocyanate-conjugated sec-
ondary antibodies were applied for 2 h to visualize staining: a goat
antimouse antibody (1:64 dilution; Sigma) was used for insulin or glucagon
and a goat antirabbit antibody (1:64 dilution, Sigma) for somatostatin.
Fluorescence was visualized using the same confocal system. In the case of the
immunocytochemistry in intact islets, the same optical section was maintained
as previously described (4). During all the inmmunochemistry, the pre-
paration was continuously monitored by acquiring images (1 image/min) in
the transmitted-light channel of the confocal microscope with a different
wavelength from that used for immunodetection. Additionally, to avoid any
movement of the sample derived from manipulation, we applied all the
elements of the immunocytochemistry with the perfusion system at a very low
rate ﬂux. Because of the preparation’s thickness, it is difﬁcult for antibodies to
stain the center of the whole islets, as has been previously reported (4,9,11).
However, this is not a limitation for our experiments, given that the outer cell
layers surrounding the center are represented by all the cell types that form the
islet (4,9,11).
Cell viability test
After autoﬂuorescence was recorded, the viability of the cells was tested in
separate samples by loading them with 1 mM ethidium homodimer-1 and 2
mM calcein/acetoxymethyl ester (AM) (Molecular Probes, Madrid, Spain)
for 15 min. Ethidium only stains the nucleus of cells whose plasma mem-
brane integrity is compromised. Calcein/AM is a nonﬂuorescent probe that
diffuses into the cell interior, where cytosolic esterases cleave it to produce a
ﬂuorescent product that is retained in the cytosol. Thus, living cells become
green if their plasma membrane and enzymatic capacity remain intact. These
probes were visualized with standard rhodamine and ﬂuorescein conﬁgu-
rations, respectively.
Ca21 imaging
Cells were loaded with 4 mMFluo-3/AM (20 min, 37C) (Molecular Probes)
in some samples, after FAD ﬂuorescence was recorded. Cells were then
washed with the extracellular medium to eliminate the circulating dye, and
stimulated with 5 mM of adrenaline, which has been proved to speciﬁcally
induce Ca21 signals in a-cells (24,25). Cytosolic Ca21 changes were moni-
tored under the same confocal microscope at a rate of 1 image every 2–4 s.
The Ca21 probe was excited with the laser beam at 488 nm, and ﬂuorescence
was collected with a bandpass ﬁlter at 505–530 nm.
Statistical analysis and data representation
Fluorescence records were represented as the percentage of DF/F0
where F0 is the ﬂuorescence signal at the beginning of a record and DF is
F  F0. Student’s t-test (p , 0.05) was performed with commercial
software (SigmaPlot, Jandel, San Rafael, CA). Some data is shown as
mean 6 SE.
RESULTS
Glucose-induced metabolic changes in
pancreatic b-cells in the intact islet
Redox ﬂuorescence microscopy has been employed as a
noninvasive technique to evaluate the involvement of metab-
olism activation in the signal transduction cascade that leads
to insulin release in the pancreatic b-cell (16,18). Neverthe-
less, conventional optical techniques have several limitations
to spatially and temporally resolve physiological variables in
non-b-cells, especially when they are in the intact islet of
Langerhans. These classical methods are mainly hindered
by the out-of-focus information coming out from adjacent
points other than those located in the focal plane. This is
particularly noteworthy in the case of the islet of Langerhans,
where a minority of non-b-cells are scattered throughout a
cellular network mostly dominated by the pancreatic b-cell
population. Consequently, signals coming from the former
cells are masked by the b-cell-dominated average signal
(4,11). However, problems derived from out-of-focus infor-
mation are almost entirely eliminated by optical sectioning
methods (Fig. 1).
In Fig. 2 we show an 8-mm optical slice of an intact islet of
Langerhans and the temporal change of ﬂavoprotein ﬂuo-
rescence in response to glucose. By increasing glucose
concentrations there was a corresponding dose-dependent
decrease in ﬂuorescence as a result of FAD reduction (Fig. 2
B). NAD(P)H ﬂuorescence is initiated in both compartments:
a small fraction comes from cytosol because of glycolysis,
whereas a main component arises from the mitochondria due
to the TCA cycle activation (22,26). In contrast, ﬂavoprotein
signals only come from the mitochondrial compartment
(14,17,22,27). Thus, glucose-induced changes in Fig. 2 essen-
tially reﬂect graded responses of mitochondrial activation.
Because oxidative phosphorylation is highly dependent on the
mitochondrial redox potential, these ﬂuorescence changes are
likely to be coupled to increases in respiratory ATP synthesis,
which are critical in ATP-dependent insulin secretion (22,27).
Consistent with this idea, the mitochondrial uncoupler carbonyl
cyanide p-triﬂuoromethoxyphenylhydrazone (FCCP) and the
cytochrome oxidase inhibitor cyanide, which are expected to
cause maximal levels of oxidation and reduction, respectively,
produced the corresponding changes in ﬂuorescence (Fig. 2 B).
The protonophore effect of FCCP is responsible for the col-
lapse of the mitochondrial membrane potential, leading to an
increase in the respiratory rate, and thus promoting the oxi-
dation of FADH2 to FAD (28). In contrast, the electron chain
inhibitor cyanide is expected to diminish the oxidation of
reducing equivalents, producing an accumulation of the re-
duced forms (28). Four records measured from different
positions within the islet optical section are shown along with
the islet average signal, indicating a high degree of metabolic
homogeneity. This average signal mimics, to some extent, what
would be obtained with conventional optical techniques, which
mainly capture the b-cell-dominated signal. We did not observe
oscillations of the FAD signal when islets were challenged with
glucose, as has been reported in some cases for the NAD(P)H
ﬂuorescence in cells of rat islets (14).
The typical metabolic pattern shown in Fig. 2 corresponds
to the pancreatic b-cell population as conﬁrmed by immu-
nocytochemistry applied subsequently to the ﬂuorescence
record and image analysis of the same optical slice (Fig. 3).
However, such a pattern and homogeneity is not as apparent
if we analyze ﬂuorescence changes individually in the intact
islet.
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Fluorescence changes in response to glucose
in a- and d-cells
After acquiring FAD ﬂuorescence changes in response to
glucose in the intact islet, we performed immunocytochem-
istry using antiglucagon antibodies to identify a-cells in the
same optical section (Fig. 4, A and B). We observed no
evident effect when these cells were challenged with
glucose, regardless of the concentration applied. FCCP and
cyanide (CN) produced the expected ﬂuorescence changes in
a-cells, indicating both the integrity and responsiveness of
the mitochondrial metabolism, and that this optical technique
was not failing to detect FAD changes in these cells (Fig.
4 B). To further conﬁrm the viability of a-cells during redox
confocal measurements, we conducted additional experi-
ments in dispersed cultured cells (Fig. 4 C). First, we in-
cubated cells with calcein/AM and ethidium homodimer-1 in
separate samples (see Materials and Methods), after acquir-
ing FAD ﬂuorescence as shown in Fig. 4 B. All the
immunoidentiﬁed a-cells tested had a response similar to the
one shown in Fig. 4 B and retained their enzymatic activity
and plasma membrane integrity (not shown; n ¼ 12 cells
from three experiments). Second, after FAD records, cells
were loaded for 20 min with the ﬂuorescent Ca21 reporter
Fluo-3 (Fig. 4D). Then, the cells were exposed to adrenaline,
which has been proved to induce Ca21 signals in a-cells,
probably by Ca21mobilization from intracellular stores (25).
Fig. 4 D illustrates a typical adrenaline-induced Ca21 re-
sponse after monitoring FAD ﬂuorescence changes in two
immunoidentiﬁed a-cells, demonstrating the integrity of the
signaling system to induce cytosolic Ca21 elevations. Thus,
FIGURE 2 FAD ﬂuorescence changes in response to glucose monitored
in the intact islet of Langerhans. (A) Transmitted-light image of an islet and
confocal images of FAD ﬂuorescence in the presence of 3 mM glucose (G),
25 mM glucose, 10 mM FCCP, and 2 mM CN (top left to bottom right).
Optical section, 8 mm; scale bar, 100 mm. Areas from which ﬂuorescence
changes are represented in B are also indicated. (B) Changes in ﬂuorescence
from four different areas of 20 3 20 mm are plotted as the percentage of
(F F0)/F0, where F0 is the ﬂuorescence at the beginning of the record. Red
line shows the average ﬂuorescence from the whole optical section of the
islet selected for these measurements. These results are representative of
nine islets. Glucose concentrations are given in millimolars. FCCP and CN
were applied at 10 mM and 2 mM, respectively.
FIGURE 3 Metabolic changes in response to glucose in immunoidentiﬁed
pancreatic b-cells. (A) Once ﬂuorescence records were acquired, the islets
were treated with antiinsulin antibodies to identify pancreatic b-cells. The
images show the immunoﬂuorescence (1) for the same optical section selected
for the autoﬂuorescence (2) record. Scale bar, 20 mm. (B) Fluorescence
changes from two immunoidentiﬁed b-cells referred to as b1 and b2 are
shown. The position of these cells is also indicated in A. Glucose con-
centrations are given in millimolars. FCCP and CN were applied at 10 mM
and 2 mM, respectively.
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FIGURE 4 Glucose-induced metabolic responses in pancreatic a-cells. (A) Subsequent to ﬂuorescence records, an immunocytochemistry with antiglucagon
antibodies was performed to identify pancreatic a-cells in the intact islet. The images show the immunoﬂuorescence (1) for the same optical section selected for
the autoﬂuorescence (2) record. Scale bar, 15 mm. (B) Fluorescence changes in response to glucose of two immunoidentiﬁed a-cells (a1 and a2). A typical
b-cell record and the average signal from the whole optical section of this islet are also shown for comparison. The position of cells (a1 and a2) is indicated in
A. (C) Two different ﬁelds showing the autoﬂuorescence of dispersed islet cells. Scale bar, 30 mm. (D) In separate experiments, cells were loaded for 20 min
with Fluo-3, a ﬂuorescent Ca21 reporter, after acquiring FAD ﬂuorescence changes. Adrenaline (Adren.), which has been proved to induce Ca21 signals in
a-cells, was applied to the bath at 5 mM. Redox-associated ﬂuorescence changes (black line) and adrenaline-induced Ca21 signals (green line) from two
immunoidentiﬁed a-cells (a1 and a2) are shown in the ﬁgure. These records represent the ﬁndings of seven different experiments. The images illustrate the
incorporation of Fluo-3 in these two cells (green) and the immunoﬂuorescence with antibodies against glucagon (red) along with the transmitted-light image of
the same ﬁeld after chemical ﬁxation. A cell not positive for antiglucagon antibodies is also shown next to a2. Scale bar, 10mm. (E) Glucose-induced responses
of dispersed islet cells in culture. Records illustrate the typical patterns of immunoidentiﬁed pancreatic a- and b-cells. In all the experiments, glucose
concentrations are given in millimolars. FCCP and CNwere applied at 10mM and 2 mM, respectively. The transmitted-light (1) and ﬂuorescence (2) images on
the top illustrate the immunoidentiﬁcation of the a-cell whose record is shown in this ﬁgure. An image of the autoﬂuorescence of these cells is also shown (3).
Scale bar, 20 mm.
Mitochondrial Metabolism in Islet Cells 2645
Biophysical Journal 90(7) 2641–2650
several lines of evidence conﬁrm that the viability of a-cells
was not compromised during FAD measurements.
Once more, the islet average signal along the optical
section shows that it is indeed dominated by the b-cell
metabolic pattern (Fig. 4 B), resembling, to some extent, a
situation that would be obtained with conventional optical
techniques (4,18). These results further indicate that con-
ventional microscopy is not suitable to resolve metabolic
signals from non-b-cells in the islet. The quantiﬁcation of the
ﬂuorescence signals in response to glucose of a-cells within
the islet revealed a very small effect with 11 mM of glucose
(;4%) (see Fig. 6 A). Because cells are densely packed into
the islet, image analysis of the regions of interest became
occasionally difﬁcult to establish cell boundaries. To avoid
any potential contribution from neighboring adjacent b-cells
to the ﬂuorescence signal coming from a-cells, we per-
formed similar experiments in isolated cells cultured over-
night. Fig. 4 E shows a typical record from immunoidentiﬁed
a- and b-cells. In these conditions, the response of a-cells
to high concentrations of glucose was ,2% (see Fig. 6 B),
indicating that there probably exists a small contribution
from the b-cell signal in intact islets in the analysis shown in
Fig. 5 A. In some experiments, ﬂuorescence was recorded
every 5–10 s for 10 min when glucose was changed from 0.5
to 25 mM, giving similar results (n ¼ 5, not shown). Since
the availability of redox molecules affects oxidative phos-
phorylation (14,22,27), this minimal response of FAD
ﬂuorescence in a-cells is indicative of low respiratory ATP
synthesis in the presence of glucose. Thus, altogether, these
observations point to a limited involvement of the mito-
chondrial metabolism in the a-cell signal transduction
scheme in response to glucose.
The effect of glucose on the mitochondrial metabolism
was also monitored in immunoidentiﬁed pancreatic d-cells in
both fresh intact islets (Fig. 5, A and B) and isolated cells in
culture (Fig. 5 C). Identical results were obtained in both
approaches (Figs. 5 and 6). Glucose increased the mito-
chondrial redox potential in a dose-dependent manner.
Fluorescence changes in d-cells were, in all cases, smaller
than signals from pancreatic b-cells, probably reﬂecting the
special metabolic conﬁguration of the latter cells for
oxidative glucose metabolism in the mitochondria (29,30).
To further demonstrate these particular metabolic patterns,
we also monitored the signal changes derived from NAD(P)H
FIGURE 5 Glucose-induced metabolic responses in pancreatic d-cells. (A) Once measurements of autoﬂuorescence were performed, pancreatic d-cells were
identiﬁed by means of an immunocytochemistry with antisomatostatin antibodies. The image shows the immunoﬂuorescence for the same optical slice selected
for FAD ﬂuorescence records. Scale bar, 15 mm. (B) Changes in ﬂuorescence in response to glucose of an immunoidentiﬁed d-cell. A typical b-cell record and
the average signal from the islet whole optical section are also shown for comparison. The position of the represented cells is indicated in A. (C) Evolution of
FAD ﬂuorescence in dispersed islet cells in culture. These records illustrate the typical patterns of immunoidentiﬁed pancreatic d- and b-cells. Glucose
concentrations are given in millimolars.. FCCP and CN were applied at 10 mM and 2 mM, respectively. The transmitted-light (1) and ﬂuorescence (2) images
on the top illustrate the immunoidentiﬁcation of the d-cell whose record is shown in this ﬁgure. An image of the autoﬂuorescence of these cells is also shown
(3). Scale bar, 15 mm.
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autoﬂuorescence using conventional microscopy and dis-
persed cells (see ﬁgure in Supplementary Material.). The
pattern of the NAD(P)H signal in the presence of glucose,
FCCP, and CN was inverse to the one obtained for the FAD
ﬂuorescence, since these two molecules generate opposite
ﬂuorescence proﬁles when a change in the metabolic status
takes place (16,22,27,28). The analysis of the NAD(P)H
ﬂuorescence is more complicated: a small fraction comes from
the cytosol because of glycolysis, whereas a main component
arises from the mitochondrial activation (22,28). Nevertheless,
the results obtained with NAD(P)H ﬂuorescence pointed to a
particular metabolic response in each cell type, which was
very similar to the pattern found with FAD measurements.
DISCUSSION
In this study, we have used redox confocal microscopy to
monitor the mitochondrial metabolic changes in response to
glucose of unambiguously identiﬁed a-, b-, and d-cells in
fresh intact islets and dispersed in culture. So far, speciﬁc
studies addressing the physiological behavior of non-b-cells
are not abundant, despite the importance of these cell types
for the physiology and pathophysiology of the islet of
Langerhans (3,31). Existing information about non-b-cells is
even more infrequent when considering reports dealing with
fresh intact islets, a preparation closer to the physiological
situation, as evidenced by in vivo studies (12,13). Although
biochemical investigations have certainly provided impor-
tant data using cell puriﬁcation protocols, which are not
always free from partial contamination, these methods fail to
spatially and temporally track cellular variables in individual
islet cells (32–35). Conventional optical and imaging tech-
niques present intrinsic difﬁculties for resolving non-b-cells
in the intact islet because of the limitations derived from the
out-of-focus information, along with the scarcity of these cell
types. Alternatively, as we have shown in this study and in
previous reports, optical-sectioning methods are valuable
tools for monitoring cellular parameters from individual cells
in intact islets (4,11). This is particularly noteworthy to track
non-b-cell physiology. Besides the important limitation
imposed by the minor representation of non-b-cells in the
islet, another major drawback to investigating these cells is
the lack of identiﬁcation patterns. In addition to the elec-
trophysiological and Ca21-signaling typical patterns previ-
ously reported (4,9,10,36), our observations in this study
allow for another physiological criterion, based on charac-
teristic metabolic responses, to identify these cells in the
intact islet of Langerhans.
Some studies addressing b-cell metabolism have mea-
sured NAD(P)H ﬂuorescence changes. This maneuver, how-
ever, entails some analysis complications since the NAD(P)H
signal does not allow cytosolic glycolysis and mitochondrial
metabolism to be distinguished (22,26,27). Although some
efforts have been made to spatially resolve NAD(P)H signal
from both cell compartments, these experimental procedures
involved the culture of islets for several days on an ex-
tracellular matrix to allow them to spread out (26,37). This
situation may dramatically differ from physiological behavior,
given that studies with islets cultured for long times indicate
important differences (12,13,38,39). However, the FADﬂuores-
cence signal originates from the mitochondria and is used as an
intracellular probe of the mitochondrial metabolic state and the
respiratory ATP synthesis in many cell types (22,27,40). In the
pancreatic b-cell, mitochondrial activation is a key event in
the current signaling model for glucose-mediated insulin secre-
tion (14). Glucose metabolism modiﬁes the cellular redox state,
increasing the concentration of nucleotide carriers of reducing
power, NAD(P)H and FADH2, which participate in the electron
transport chain and, thereby, facilitate ATP production by
oxidative phosphorylation (14,16,17,41). The resulting increase
in the ATP/ADP ratio is responsible for KATP channel inhi-
bition and the depolarization-induced Ca21 increase that pre-
cedes exocytosis (2,21). All these metabolic and ionic changes
lead to insulin secretion.
FIGURE 6 Percentage of FAD ﬂuorescence change of each cell type in
the intact islet (A) and in culture (B). The percentage was calculated as the
change in ﬂuorescence from the signal obtained with 0.5 mM glucose.
Results are shown as the mean6 SE from 19 b-cells (three islets), 9 a-cells
(four islets), and 7 d-cells (four islets) and from 45 b-cells (nine cultures), 36
a-cells (six cultures), and 13 d-cells (four cultures). All values were found to
be signiﬁcant except the ﬂuorescence change obtained in a-cells with 3 mM
glucose (p , 0.05, compared with basal values).
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However, the model for glucose-induced signal transduc-
tion in a-cells is still a matter of debate at this time. The
stimulation of glucagon secretion depends on multiple levels
of control, including low glucose concentrations, amino
acids, and hormonal and neuronal inputs, whose dominance
varies depending on the physiological situation (7,42–44).
Notwithstanding the signiﬁcance of all these regulatory
factors, glucose exerts a signiﬁcant control on the a-cell
function (10,24,33,45). Several studies have contributed
important data regarding the glucose dependence of the
a-cell response, showing its opposite behavior compared to
b-cells in terms of electrical activity, Ca21 signaling, and
secretion when glucose levels are increased (4,10,11,36,45).
Recently, several reports have speciﬁcally demonstrated a
direct effect of glucose on a-cell glucagon secretion, inde-
pendent of other factors (24,46). Many signiﬁcant features in
a-cells, such as the existence of KATP channels, glucose-
dependent electrical activity, and Ca21 signals, as well as
Ca21-induced exocytosis, have made it possible to propose
a model to explain glucose regulation of glucagon release
mainly based on ionic events (10,47). As proposed for
b-cells, it has been hypothesized that glucose metabolism
may be a critical link that couples these electrical and Ca21
changes with glucagon secretion (10,47). However, glucose-
induced metabolic variations and the activation of the
mitochondrial function have not been explored in unambig-
uously identiﬁed a-cells. Our observations indicate that,
contrary to the situation for b-cells, mitochondrial oxidative
metabolism is not a major step in the glucose-mediated
signaling pathway for the regulation of glucagon release in
a-cells. Thus, other metabolic processes might have a
primary role. In this aspect, our results are in agreement with
biochemical studies using puriﬁcation protocols or lines
derived from islet cell types that have reported the existence
of metabolic differences between islet cells. It is worth
mentioning that adenine nucleotide changes in response
to glucose occur in b- but not in a-cells, suggesting a high
degree of coupling between cytosolic glycolysis and mito-
chondrial respiratory ATP synthesis in the former cell type
that would not take place in a-cells (32). Actually, related
biochemical studies point to a prevalence of anaerobic
glycolysis in non-b-cells (most likely puriﬁed a-cells) as
opposed to an aerobic metabolism in b-cells (48). This idea
is also supported by the ﬁnding that the ratio lactate
dehydrogenase/mitochondrial glycerol phosphate dehydro-
genase is low in b-cells, which would favor mitochondrial
oxidation, but elevated in non-b-cells (29). It is unlikely
that this limited involvement of the a-cell mitochondria in
glucose metabolism is attributable to signiﬁcant restrictions
in upstream reactions involved in glucose utilization and/or
uptake. In fact, although a- and b-cells possess different
glucose transporters and kinetics for sugar incorporation,
glucose transport is not rate-limiting because it exceeds glu-
cose utilization by several times, the latter process being
similar in both cell types (34,49,50). Given that glucose
metabolism also participates in many other cell processes
other than glucagon secretion (51,52), our results in a-cells
would also limit the involvement of the mitochondrial
metabolism as a central element in other glucose-mediated
signaling and energetic pathways.
The situation, however, is quite different for the d-cell.
Although information about glucose regulation of somato-
statin secretion is also scarce, several physiological charac-
teristics point to control mechanisms similar to those described
for b-cells. Increasing glucose concentrations activates elec-
trical activity, Ca21 signals, and secretion, a situation analo-
gous to the one occurring in b-cells, and opposed to the a-cell
response (4,6,8,10,11,53). KATP channels are present in the
d-cell and their closure by sulphonylureas induces cytosolic
Ca21 elevations and somatostatin secretion (11,54). It has been
suggested that, upon glucose stimulation, these metabolic
regulated K1 channels may link the metabolic redox state of
the cell with changes of the membrane potential, which may
lead to Ca21 entry and somatostatin secretion (1,9). Therefore,
it seems very likely that d-cells have a stimulus-secretion
coupling scheme very similar to the one established in the
b-cell, as has been previously proposed (1,9). Our results in
d-cells agree with this signal transduction process. The data
reported here indicate that glucose stimulates the activation of
the mitochondrial oxidative metabolism and changes in the
cellular redox state, probably fulﬁlling a function similar to the
one in the b-cell. Our observations are also consistent with
studies that emphasize the critical role of the glucose mito-
chondrial metabolism for other functions in d-cells, such as
gene expression (55). Although the stimulus-secretion cou-
pling is well-understood in the pancreatic b-cell, further work
is needed to fully understand the regulation of a- and d-cells.
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